JESSICA KING: Open Payments
NPI 1982317814 · WINCHESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,011 in 118 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $2,189 · 2025 $3,011
Food & beverage: $2,837Education: $175
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $650 |
| Janssen Biotech, Inc. | 12 | $544 |
| GENZYME CORPORATION | 11 | $381 |
| ABBVIE INC. | 23 | $234 |
| Organon LLC | 8 | $214 |
| Regeneron Healthcare Solutions, Inc. | 9 | $205 |
| Incyte Corporation | 7 | $168 |
| Amgen Inc. | 8 | $164 |
| Galderma Laboratories, L.P. | 13 | $159 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
Products named: DUPIXENT, Bimzelx, TREMFYA, SKYRIZI, OPZELURA, OTEZLA, NEMLUVIO, TALTZ.
Industry payments across MA — which companies pay providers there.
